Drug intelligence / Profile preview

Scarex

Development stage: Unknown
Lead developer: Omega Remedies
Modality: Small Molecules
Administration: Topical

Overview

Scarex is a topical scar reduction gel developed by Omega Remedies P Ltd, an Indian consumer healthcare company. The product is formulated to minimize the appearance of scars and blemishes resulting from acne, surgery, or physical injuries. It is designed to promote natural skin regeneration and soften scar tissue, potentially through the stimulation of collagen production and skin-brightening properties. As a cosmeceutical product, it features a lightweight, non-greasy formula suitable for daily application on all skin types.

Brand names: Scarex
Other names: Scarex Gel

Beyond the preview

Go deeper on Scarex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scarex.

Explore the full profile